Jinan Hongyuan Chemical Co.,Ltd

Jinan Hongyuan Chemical Co.,Ltd

86-13954187575

Jinan Hongyuan Chemical Co.,Ltd
ホーム > ブログ
April 29, 2021
Corning Jerry's PD-L1/CTLA-4 bispecific antibody KN046 and Pfizer Inleader(R) (Axitinib) jointly develop Phase II clinical trials

April 29, 2021/PRNewswire/--Corning Jereh Biopharmaceuticals announced that it has reached a clinical trial and drug supply cooperation with Pfizer to evaluate the combination of KN046 and Inlead® (a

April 28, 2021
The second batch of national mining expiry contract renewals are open! These points need attention

In 2020, the renewal of the first batch of national bulk purchases has been completed. Most of the pilot cities follow the alliance's selected price. The alliance area mainly chooses to renew the cont

April 27, 2021
World Intellectual Property Day! 10 billion anti-cancer drugs are not selected in the "Encouraged Generic Drug Catalog", and there are no corporate generics for the 2 major varieties...

The World Intellectual Property Day (TheWorldIntellectualPropertyDay) was established by the World Intellectual Property Organization on April 26, 2001. Today (April 26) is the 21st World Intell

April 26, 2021
The global pharmaceutical innovation index list is released! Eli Lilly won the championship, 4 innovative pharmaceutical companies made the list for the first time, BeiGene, Moderna...

The pharmaceutical R&D investment is large, the cycle is long, and the risk is high. How to judge the future potential of a pharmaceutical company? Innovative R&D and clinical translation capa

April 25, 2021
Heavy! The first Chinese pharmaceutical company to submit a Seretide® generic drug application to the U.S. FDA

On April 1, the American pharmaceutical company Lannett (NYSE: LCI) issued an announcement stating that its strategic partner Respirent Pharmaceuticals has submitted Advair® Diskus® (Chinese trade n

April 23, 2021
Junshi Bio-PD-1 monoclonal antibody first-line treatment of esophageal cancer phase III clinical study reached the primary endpoint

On April 22, Junshi Biotechnology issued an announcement that its self-developed anti-PD-1 monoclonal antibody drug teriprizumab combine

April 22, 2021
Top 10 "Medical Ecological Innovation Labs" in the world: Cardano, BJC Medical, Google...

From remote patient monitoring to translational science, emerging technologies are disrupting the medical industry. With the development of th

April 20, 2021
Baiji Shenzhou new production base approved for commercial production

Beijing, China and Cambridge, Massachusetts, USA April 8, 2021, Baiji Shenzhou (NASDAQ: bgne; SEHK: 06160) is a biotechnology company in the commercial stage, focusing on the development and commercia

February 01, 2021
Two anti-PD-L1 McAbs are to be included in the breakthrough treatment

On January 28, 2021, CDE announced the list of two breakthrough treatment varieties to be included.

February 01, 2021
In 2020, four car-t enterprises will apply for and be approved at the same time, and six enterprises will raise more than 3.2 billion yuan in total

A few days ago, according to the official website of the State Drug Administration (nmpa), the application for the listing of Fosun Kate car-t product akilunsai injection has entered the stage of admi

January 29, 2021
2020 inventory: Top 10 clinical trial failure cases! Roche is the most, AstraZeneca, Sanofi, GSK

It is a highly subjective task to list the most failed clinical trials in 2020, and the trials on the list need to have a significant impact on pharmaceutical companies and patients targeted by drugs.

January 29, 2021
2020 inventory: 150 billion US dollars antibody drug market competition intensifies, domestic innovative pharmaceutical enterprises rise rapidly, Hengrui, Junshi, Xinda

Antibody drugs only have a history of more than 30 years, and have entered the outbreak stage in the past five years. By the end of 2020, the US FDA has approved 99 Ki

January 26, 2021
100 billion US dollars diabetes drug market, dulaglutide compound growth rate of 124.2% in five years

Overview of diabetes Definition of diabetes Diabetes is caused by genetic and environmental factors, with abnormal glucose metabolism as the main performance of the disea

January 26, 2021
Domestic car-t therapy will be on the market soon! How much room for price reduction in cell therapy?

Cellular immunotherapy has experienced a long history of development, and ushered in a breakthrough in recent years. Up to now, there are 366 car-t products under research in the global market, and th

January 23, 2021
Five important issues in the field of gene therapy in 2021

Three years ago, the U.S. FDA granted a landmark approval for luxturna to treat an inherited retinal disease (IRD) that can cause blindness. This is the first real gene therapy in the U.S. market, mar

January 23, 2021
"Biological missile" ADC drugs usher in the golden age, challenge the next 100 billion market!

In 2000, the first ADC drug appeared on the market, but it has been tepid. Until 2019, the FDA has approved three ADC drugs (poly ivy, padcev and enhertu), and ADC drugs known as "biological missiles"

January 20, 2021
2020 inventory: Top 10 keywords in pharmaceutical circle! The seventh one deserves it!

In 2020, with the gradual implementation of "4 + 7 procurement with volume" nationwide expansion, the medical reform will continue to tackle the difficulties, the route of deepening the reform of the

January 20, 2021
3.2 billion market to meet changes? Pfizer "monopolizes three yuan" in the fourth batch of centralized purchasing?

Cosmic pharmaceutical company, Pfizer, the world's largest pharmaceutical company, is under the impact of volume procurement policy, and its future direction is more complicated. According to the data

January 18, 2021
High level set the tone of "normalization and institutionalization of centralized drug procurement"! 2021 will be the real bidding year in the past ten years!

On January 15, in one day, there are three things worth pondering: Around 5 p.m., the four batches of national mining plan, which was rumored to be introduced this week, finally came to

January 16, 2021
Nuocheng Jianhua and Shanghai Pharmaceutical Science Park reach strategic cooperation

Beijing, January 13, 2021 / AP / -- a biomedical high-tech company, nuocheng Jianhua (stock exchange of Hong Kong Code: 09969), has reached a strategic cooperation with Shanghai Pharmaceutical Science

January 16, 2021
2020 inventory: peak sales forecast of new drugs approved by FDA and EMA in the United States! Gilead, vertex, Roche, Pfizer, Novartis

2020 is a "eventful year" for the pharmaceutical industry. Many pharmaceutical companies around the world are developing covid-19 therapeutic drugs or vaccines at a fanatical pace. So far, covid-19 ha

January 13, 2021
Inventory in 2020: analysis of imported ind varieties of "chemical drug category 1", Roche, Novartis, Baiji, Xinda

In 2020, China's domestic new drug ind declaration will reach a new record. Although the global epidemic has brought many difficulties, it has not delayed the enthusiasm and pace of domestic new drug

January 12, 2021
Interim Measures for designated management of medical security in medical institutions and Interim Measures for designated management of medical security in retail pharmacies

1、 What is the background of the promulgation of the Interim Measures for the designated management of medical security in medical institutions and the Interim Measures for the designated management

January 11, 2021
Proper storage of α - lipoic acid

[basic characters of α - lipoic acid] α - lipoic acid, light yellow powder crystal, almost tasteless. The solubility in water is about 1 g / L (20 ° C). It is soluble

ホーム

Product

Whatsapp

私たちに関しては

お問い合わせ

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

送信